Novartis is shutting down Colorado plant, laying off 400 employees after overestimating gene therapy demand | Fierce Pharma
Alcon becomes a separately traded standalone company | Novartis
Investors | Novartis
Novartis to spin off generics business Sandoz next year | Reuters
Novartis - YouTube
Novartis's nuclear vision starts to take shape | Evaluate
Two Children Die After Receiving Novartis Gene Therapy | The Scientist Magazine®
Novartis - Wikipedia
Novartis CEO Targets 20 Key Drugs as Potential Blockbusters - DCAT Value Chain Insights
Primary analysis results from Novartis pivotal JULIET trial show Kymriah(TM) (tisagenlecleucel) sustained complete responses at six months in adults with r/r DLBCL, a difficult-to-treat cancer
Six Former and Current Novartis AG Execs Charged With Bribing Doctors in Korea | BioSpace
NOVN Stock Price and Chart — SIX:NOVN — TradingView
Novartis' $3B prospect beats AstraZeneca blockbuster in phase 3
Novartis sells phase 3 rare disease drug to Pharming | Fierce Biotech
Novartis' Cosentyx receives MHRA approval for two types of juvenile idiopathic arthritis - PMLiVE
HazardEx - Novartis plant leak causes hospitalisation of six workers
AGC Biologics to buy Novartis facility in Longmont – Colorado Hometown Weekly
Moving Away from Asthma and COPD, Novartis Hones in on 20 Approvals by 2026 | BioSpace
